ow dose-CT for differentiation between AECOPD and pneumonia. An effective tool for diagnosis? - Maastricht COPD CT study (MCCT)

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 5 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

Trial ended prematurely

•Adults, either sex, older than 40 years of age;
•Smoking history of 10 Pack Years or more;
•Diagnosis of COPD stages I-IV, class A-D, as defined by the Global initiative for chronic Obstructive Lung Disease (GOLD);
•Doctor*s diagnosis of AECOPD (clinical presentation of a patient complaining of an acute change of symptoms that is beyond normal day-to-day variation - baseline dyspnoea, cough and/or sputum production);
•Patients must sign and date an informed consent prior to inclusion in the study.

•Progressively fatal disease, or life expectancy <=6 months;
•Women who are breast feeding or are pregnant;
•Patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study;
•Patients participating in an intervention study which influences outcomes;
•Un-ability to lie flat for the performance of CT-scan.

发起方

Medisch Universitair Ziekenhuis Maastricht